March 2016

0
Approved alternatives to Coumadin (collectively known as NOACs) for anticoagulation in the setting of atrial fibrillation include dabigatran, rivaroxaban, apixaban, and edoxaban. When compared to warfarin they have all been at least as effective at reducing the risk of stroke and blood clots and are associated with similar or lower bleeding complications. There is little disagreement that adults should undergo cholesterol screening. The question of if and when to screen children has been more contentious.
To continue reading this article you must be a paid subscriber

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!

LEAVE A REPLY

Please enter your comment!
Please enter your name here